| Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease J Maul, C Loddenkemper, P Mundt, E Berg, T Giese, A Stallmach, M Zeitz, ... Gastroenterology 128 (7), 1868-1878, 2005 | 768 | 2005 |
| Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD K Rieger, C Loddenkemper, J Maul, T Fietz, D Wolff, H Terpe, B Steiner, ... Blood 107 (4), 1717-1723, 2006 | 307 | 2006 |
| Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans P Bacher, T Hohnstein, E Beerbaum, M Röcker, MG Blango, S Kaufmann, ... Cell 176 (6), 1340-1355. e15, 2019 | 263 | 2019 |
| Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART HJ Epple, C Loddenkemper, D Kunkel, H Tröger, J Maul, V Moos, ... Blood 108 (9), 3072-3078, 2006 | 260 | 2006 |
| Vedolizumab induction therapy for inflammatory bowel disease in clinical practice–a nationwide consecutive German cohort study DC Baumgart, B Bokemeyer, A Drabik, A Stallmach, S Schreiber, ... Alimentary pharmacology & therapeutics 43 (10), 1090-1102, 2016 | 162 | 2016 |
| Use of intestinal ultrasound to monitor Crohn’s disease activity T Kucharzik, BM Wittig, U Helwig, N Börner, A Rössler, S Rath, C Maaser, ... Clinical Gastroenterology and Hepatology 15 (4), 535-542. e2, 2017 | 158 | 2017 |
| Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease–a prospective multicenter observational study A Stallmach, C Langbein, R Atreya, T Bruns, A Dignass, K Ende, J Hampe, ... Alimentary pharmacology & therapeutics 44 (11-12), 1199-1212, 2016 | 149 | 2016 |
| Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Clinical Gastroenterology and Hepatology 7 (9), 981-987, 2009 | 143 | 2009 |
| The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy CRH Hedin, SR Vavricka, AJ Stagg, A Schoepfer, T Raine, L Puig, ... Journal of Crohn's and Colitis 13 (5), 541-554, 2019 | 91 | 2019 |
| Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Journal of Crohn's and Colitis 4 (2), 194-198, 2010 | 85 | 2010 |
| H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy JF Rahier, P Papay, J Salleron, S Sebastian, M Marzo, L Peyrin-Biroulet, ... Gut 60 (4), 456-462, 2011 | 75 | 2011 |
| Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome M Heindl, N Händel, J Ngeow, J Kionke, C Wittekind, M Kamprad, ... Gastroenterology 142 (5), 1093-1096. e6, 2012 | 68 | 2012 |
| EndoClot polysaccharide hemostatic system in nonvariceal gastrointestinal bleeding JC Preiß, C Barmeyer, N Bürgel, S Daum, HJ Epple, U Günther, J Maul, ... Journal of clinical gastroenterology 50 (10), e95-e100, 2016 | 53 | 2016 |
| Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled study F Beigel, N Teich, S Howaldt, F Lammert, J Maul, S Breiteneicher, C Rust, ... Journal of Crohn's and Colitis 8 (11), 1471-1479, 2014 | 52 | 2014 |
| Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations J Maul, M Zeitz Langenbeck's archives of surgery 397, 1-10, 2012 | 32 | 2012 |
| Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations J Maul, M Zeitz Langenbeck's archives of surgery 397, 1-10, 2012 | 31 | 2012 |
| Modulation of systemic antigen‐specific immune responses by oral antigen in humans K Kapp, J Maul, A Hostmann, P Mundt, JC Preiss, A Wenzel, A Thiel, ... European journal of immunology 40 (11), 3128-3137, 2010 | 31 | 2010 |
| Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis G Fluhr, J Mayerle, E Weber, A Aghdassi, P Simon, T Gress, T Seufferlein, ... BMC gastroenterology 13, 1-6, 2013 | 27 | 2013 |
| Analysis of FOXP3 protein expression in human CD4 (+) CD25 (+) regulatory T cells at the single-cell level C Loddenkemper, J Maul, E Berg, H Stein, M Zeitz, R Duchmann European journal of immunology 36 (1), 245-246, 2006 | 25 | 2006 |
| European Crohn’s and Colitis Organization (ECCO). Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile … S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Clin Gastroenterol Hepatol 7 (9), 981-7, 2009 | 22 | 2009 |
